Skip to main content
Qiagen N.V. logo

Qiagen N.V. — Investor Relations & Filings

Ticker · QIA ISIN · NL0015001WM6 LEI · 54930036WK3GMCN17Z57 F Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2014-07-30 Earnings Release
Country NL Netherlands
Listing F QIA

About Qiagen N.V.

https://www.qiagen.com/

Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.

Recent filings

Filing Released Lang Actions
QIAGEN reports second quarter and first half 2014 results and announces launch of new $100 million share repurchase program
Earnings Release Classification · 100% confidence The document is a press release from QIAGEN N.V. announcing its financial results for the second quarter and first half of 2014. It contains key financial highlights, tables comparing current and prior year performance, and management commentary on business drivers. While it provides financial data, it is structured as an initial announcement of results (Earnings Release) rather than a full statutory interim report. It fits the definition of an Earnings Release (ER) as it focuses on key highlights, adjusted figures, and management's summary of performance. H1 2014
2014-07-30 English
Regulatory Filings 2014
Regulatory Filings
2014-06-26 English
Regulatory Filings 2014
Regulatory Filings Classification · 95% confidence The document is a detailed response letter from the company's legal counsel to the SEC's comments on the company's Form 20-F for the fiscal year ended December 31, 2013, and Form 6-K for the quarterly period ended March 31, 2014. It addresses specific accounting and financial reporting issues raised by the SEC staff, referencing accounting standards (ASC codes) and explaining the company's accounting treatments. The document is not the actual Form 20-F or Form 6-K report itself, but a correspondence related to regulatory review and comment. It is a regulatory filing responding to SEC comments, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS). The document length (15,000 characters) and content confirm it is a substantive regulatory correspondence, not a brief announcement or certification letter.
2014-06-06 English
SD
Regulatory Filings Classification · 95% confidence The document is a Form SD filed with the SEC, titled 'Specialized Disclosure Report,' specifically addressing conflict minerals disclosure for the calendar year ended December 31, 2013. Form SD is a specialized regulatory filing required under Rule 13p-1 of the Securities Exchange Act, focusing on conflict minerals sourcing. The content is a detailed disclosure about the company's conflict minerals inquiry and findings, not a full annual or quarterly financial report. It is not an announcement of a report but the report itself, yet it is a specialized disclosure report distinct from typical financial reports like 10-K or IR. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2014-05-30 English
Regulatory Filings 2014
Regulatory Filings
2014-05-29 English
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed with the SEC by QIAGEN N.V. It explicitly contains a 'U.S. GAAP Quarterly Report' for the period ended March 31, 2014, including condensed consolidated financial statements (balance sheets, income statements, etc.). Since it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2014
2014-05-08 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.